雾化吸入疗法在支气管哮喘中的应用.ppt

糖皮质激素雾化吸入疗法在支气管哮喘中的应用;内 容;内 容;;Centers for Disease Control and Prevention. MMWR. 2007;56(28):713;沈华浩 哮喘手册（第二版）人民卫生出版社 2009，170-171;儿童哮喘诊断标准;儿童哮喘分期与分级 ;儿童哮喘治疗目标;儿童哮喘的防治原则;吸入激素; 2.哮喘急性发作期的治疗;哮喘急性发作期的治疗原则;Global Strategy for Asthma Management and Prevention. Updated 2009. ;中国儿童支气管哮喘诊断和防治指南 --2008;雾化吸入布地奈德治疗哮喘急性发作的疗效;雾化吸入布地奈德（1mg/剂）具有快速平喘作用，且与全身用激素协同作用;*患儿有明显呼吸困难，氧饱和度≤90％;Singhi SD.Kumar L,et al Efficacy of nebulized budesonde compared to oral prednisolone in acute bronchial asthma Acta Paediatr.1999;88(8)835-40;Singhi SD.Kumar L,et al Efficacy of nebulized budesonde compared to oral prednisolone in acute bronchial asthma Acta Paediatr.1999;88(8)835-40;Matthews et al. Acta Paediatr 1999; 88: 841–843;内 容;中华医学会儿科学分会呼吸学组. 儿童支气管哮喘诊断与防治指南,中华儿科杂志.2008;46:745-53;儿童哮喘需要维持治疗;中华医学会儿科学分会呼吸学组. 儿童支气管哮喘诊断与防治指南,中华儿科杂志.2008;46:745-53;1.中华医学会儿科学分会呼吸学组 《中华儿科杂志》编辑委员会. 儿童支气管哮喘诊断与防治指南.中华儿科杂志. 2008,46(10):745-53. 2.The Global Strategy for the Diagnosis and Mangament of Asthma in Children 5 Years and Younger (updated 2009).;吸入型糖皮质激素治疗哮喘的优点（GINA2009);即使已减至最低剂量，仍然要求3～6个月评估一次，以GINA所规定的完全控制为最终目标，予以长期维持;雾化吸入糖皮质激素治疗 哮喘慢性持续期和临床缓解期的疗效;*12时有基线及基线后数值的受试者数;Szefler SJ, et al. Comparative study of budesonide inhalation suspension and montelukast In young children with mild persistent asthma . J Allergy Clin Immunol. 2007; 120:1043-50;S. Zielen,et al.Current Medical Research and Opinion.2006;22(2): 367–373.;S. Zielen,et al.Current Medical Research and Opinion.2006;22(2): 367–373.;P 0.05 VS未接受雾化吸入布地奈德治疗的患儿 #P 0.05 VS 未接受肥大细胞稳定剂治疗的患儿;Mclaughlin T, et al.Risk of recurrentemergency department visits or hospitalizations in children with asthma receving nebulized budesonide inhalation suspension compared with other asthma medications. Current Medical Research And Opinion.2007；23(6):1319-1328.;Mclaughlin T, et al.Risk of recurrentemergency department visits or hospitalizations in children with asthma receving nebulized budesonide inhalation suspens